Comparison of Rates of Type 2 Diabetes in Adults and Children Treated With Anticonvulsant Mood Stabilizers
Authors:
Open Access
- 5 April 2022
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 5 (4) , e226484
Abstract
Over the past several decades, the prevalence of type 2 diabetes (T2D) has increased in the US and globally.1-4 Approximately 1 in 10 people in the US were living with T2D from 2013 to 2016,1,5 and youth-onset T2D has increased in the US by approximately 5% annually from 2002 to 2015.5-7 There are several known risk factors for T2D, including lifestyle, environmental, and psychosocial factors that are key focus areas for prevention.8 Patients and clinicians would also benefit from guidance on choosing between similarly effective medications that may have different metabolic adverse effects.Keywords
This publication has 51 references indexed in Scilit:
- Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approachesDiabetologia, 2013
- Automated Detection and Classification of Type 1 Versus Type 2 Diabetes Using Electronic Health Record DataDiabetes Care, 2013
- Prescribing Trends in Bipolar Disorder: Cohort Study in the United Kingdom THIN Primary Care Database 1995–2009PLOS ONE, 2011
- A combined comorbidity score predicted mortality in elderly patients better than existing scoresJournal of Clinical Epidemiology, 2011
- Weight gain following treatment with valproic acid: pathogenetic mechanisms and clinical implicationsObesity Reviews, 2011
- The role of valproate in metabolic disturbances in bipolar disorder patientsJournal of Affective Disorders, 2010
- The Hazards of Hazard RatiosEpidemiology, 2010
- A three-country comparison of psychotropic medication prevalence in youthChild and Adolescent Psychiatry and Mental Health, 2008
- Constructing Inverse Probability Weights for Marginal Structural ModelsAmerican Journal of Epidemiology, 2008
- Weight Gain, Increased Appetite, and Excessive Food Intake Induced by CarbamazepineClinical Neuropharmacology, 1991